What Supporters Are Saying

Our coalition is united in support of the California Immunology Medical Research & Cures Initiative to advance life-saving immunology and immunotherapy research that can benefit millions of Californians.

“Immunology and immunotherapy research represents one of the most transformative frontiers in modern medicine.”

Dr. Linda Liau, M.D., Ph.D., MBA
Dr. Linda Liau, M.D., Ph.D., MBA
Professor & Chair of Neurosurgery at UCLA David Geffen School of Medicine

“Amid growing uncertainty in public health, healthcare access, and research funding, California cannot afford to fall behind. This effort is critical to keeping our state at the forefront of lifesaving innovation and protecting the health and wellbeing of our communities.”

Marketa Houskova
CEO of American Nurses Association/California

"At a time of declining federal research funding, I support the California Immunology Research & Cures Initiative because it will provide sustained support to accelerate innovation and the development of transformative immunotherapies. This initiative is essential to ensuring scientific advances can be translated into life-saving treatments that improve outcomes for patients across California."

Yichen Zhu
Graduate Student at UCLA

"As a Professor of Immunology at UCLA and leader of the Yang Engineering Immunity Lab, I develop immunotherapies for cancer, autoimmune disorders, Alzheimer’s, Parkinson’s and heart disease. With declining federal research funding, the California Immunology Research & Cures Initiative is essential to sustaining innovation and accelerating life-saving treatments for patients across California."

Dr. Lili Yang
Professor of Microbiology, Immunology and Molecular Genetics at UCLA

"As a cancer survivor, and someone who has lost many family members to cancer and other diseases like heart disease, I believe investing in immunology and immunotherapy research is where the promise resides in new therapies and cures for a myriad of diseases."

John Baker
Vice President of Philanthropy at City of Hope

"I support immunology and immunotherapy research because it is one of the few levers we have that can fundamentally change the trajectory of cancer and many immune‑driven diseases in a single generation. Sustained investment is essential to turn today’s high‑risk ideas into tomorrow’s standard, accessible treatments for California patients."

Ignacio Baselga
Clinical Trial Lead at UCLA

"The immune system is involved in all aspects of health. Many of the new therapies for cancer and autoimmune disease and vaccination have greatly advanced treatment success for these diseases."

Dr. Lewis L. Lanier, Ph.D.
Distinguished Professor Emeritus,
UC San Francisco
Member, National Academy of Sciences

“Immunology research is essential to advancing new ways to prevent, detect, and treat liver disease and liver cancer. Investing in this initiative accelerates the development of life‑saving treatments that strengthen the immune system and bring promising cures closer to the families most affected.”

Scott A. Suckow
Executive Director of the Liver Coalition

"The initiative is a meaningful opportunity to advance the science that could prevent and cure Alzheimer's disease. Immunology research is helping unlock how the brain and immune system interact — knowledge critical to the next generation of treatments. The Alzheimer's Association urges Californians to vote yes in November." 

Ken Toren
Executive Director in Northern California of the Alzheimer’s Association/AIM

"Immunotherapies are an incredible medical innovation that has helped to extend the lives of kidney cancer patients. It is my belief the onslaught of promising treatments on the horizon will most definitely have an even greater impact on kidney cancer patients and their families in the future. Our goal is to keep up the momentum through continued research in hopes of saving even more lives."

Gretchen E. Vaughan
President and CEO of the Kidney Cancer Association

“When I was diagnosed with stage 4 kidney cancer, I thought my life was over, but immunotherapy has given my family hope for the future, and perhaps a chance at a full life. Having worked in scientific research, I understand the promise these breakthroughs hold and strongly believe we must continue investing in immunotherapy research so more families can have the same hope and lives can be saved.”

Byron Olsen
Byron Olsen
Scientist and Kidney Cancer Patient

“Advances in immunology are opening new doors to slowing or stopping neurodegenerative diseases. Supporting this initiative is an investment in hope and promising scientific progress for the Frontotemporal Degeneration community." 

Meghan Buzby
Director of Advocacy & Volunteer Engagement, The Association for Frontotemporal Degeneration

“Substantially more public investment in immunology research is needed to understand the full potential of reprogramming the immune system to cure a broad range of diseases. This initiative promises to do just that.”

Dr. Keith Flaherty, M.D.
Dr. Keith Flaherty, M.D.
Director of Clinical Research at Massachusetts General Hospital Cancer Center, and Harvard Medical School Professor

"Immunotherapy is changing the future of cancer care, but patients can’t afford for research to slow down. We urgently need sustained investment to accelerate breakthroughs and bring more life-saving treatments to patients and families.”

Gina Carithers
President and CEO of the Prostate Cancer Foundation

“California has long been a global leader in scientific innovation, and we cannot afford to slow progress. Immunotherapy is opening extraordinary new possibilities not only for cancer, but also for Alzheimer’s disease and neurological disorders, and California will lead the world toward lifesaving breakthroughs.”

Dr. Vicky Yamamoto, Ph.D.
Founding Member of the World Brain Mapping Foundation

“This initiative will empower the next generation of scientists to pursue breakthrough research that can lead to new treatments and cures for some of the most serious diseases facing our society.”

Dr. Samuel Broder, M.D.
Dr. Samuel Broder, M.D.
Former Director, National Cancer Institute; Member, National Academy of Medicine

“This measure can accelerate lifesaving innovation, strengthen America’s leadership in biomedical research and bring new therapies to patients who cannot afford to wait.”

Dr. Babak Kateb
Dr. Babak Kateb
Chairman of the Board & CEO of the Society for Brain Mapping and Therapeutics

“Scientific breakthroughs don’t happen by chance – they happen when bold investments meet urgent need. By committing to immunology research now, California can turn cutting-edge discoveries into real treatments faster, giving patients new hope and ensuring the state leads in developing the next wave of cures.”

Dr. Arie Belldegrun, M.D.
Dr. Arie Belldegrun, M.D.
Leader in Life-Saving Cancer Immunotherapies; UCLA Research Professor of Urology

“I’m alive today because of the researchers and doctors who found an immunotherapy that cured my cancer. This measure will expand research and lifesaving cures to save the lives of even more patients like me.”

Andrew Dale
Andrew Dale
Immunotherapy Patient and Cancer Survivor

“Emerging insights from immunology are reshaping how we understand ALS and where new treatments may come from. This measure is a critical step toward accelerating research that can meaningfully slow disease progression. For people living with ALS, time is the one thing they don’t have, making action like this not just important, but imperative.” 

Melanie Lendnal, Senior Vice President, Policy & Advocacy
The ALS Association

“Advances in immunology and immunotherapy represent one of the most promising frontiers in medicine. What was once considered a bold and uncertain idea is now firmly established as a powerful force in modern medicine. This progress reflects years of scientific persistence and early investment in unconventional approaches. Today, science is mature enough to take full advantage. That opportunity is too important to leave unsupported.”

Michael Milken 
Michael Milken 
Chairman, Milken Institute; Chairman, Prostate Cancer Foundation

"As a mother navigating my son's journey through leukemia treatment and now a complex, unexplained immune condition, I've seen both the promise and the gaps in immunology. Families like ours need more treatments, more breakthroughs, and more hope. Investing in immunology research gives families like ours a fighting chance, not just against cancer, but against everything that comes after."

Bhavika Taunk
Bhavika Taunk
Mother & Advocate for Childhood Cancer Survivors

"Blood Cancer United strongly supports the California Immunology Research & Cures Initiative. This measure will strengthen California’s research and clinical trial infrastructure, helping ensure patients can access cutting-edge therapies sooner while accelerating the search for cures."

Adam Zarrin, Director of State Government Affairs
Blood Cancer United

"The Parkinson Association of Northern California supports the California Immunology Research & Cures Initiative because it drives disease-modifying research focused on slowing or stopping Parkinson’s, not just managing its symptoms. This work advances our understanding of the gut-immune-brain connection, where the disease may originate, and holds real potential to save lives.”

Jan Whitney, Executive Director
Parkinson Association of Northern California

"We stand at a threshold of exciting breakthroughs in treating intractable diseases. We need to support cure-finding research in immunology and immunotherapies."

Steve A. Kay, Ph.D., D.Sc., FRS
Steve A. Kay, Ph.D., D.Sc., FRS
Professor and Director, University of Southern California; Member, National Academy of Sciences

"Having spent decades at the forefront of disease prevention, I understand the promise of vaccines, therapies and cures that come from immunology research. Supporting this bond is a vital step toward decoding the human immune system and accelerating the breakthroughs needed to end our most devastating diseases."

Wayne Koff, Ph.D., Founding CEO
Wayne Koff, Ph.D., Founding CEO
Human Immunome Project

"We believe California should lead the nation in science funding and this measure is a prime example of how strategic investment can improve the health and outcomes of all Californians."

Margaret Hitchcock, Ph.D., President
California Colorectal Cancer Coalition

"As a physician-scientist who has spent my career developing vaccines and advancing global health, I know that immunology research is our most powerful tool for preventing and curing diseases ranging from cancer to Alzheimer’s. Investing in this bond will accelerate lifesaving discoveries, strengthen our preparedness for future health threats and deliver hope to millions of families."

Dr. Peter Hotez, M.D., Ph.D.
Dr. Peter Hotez, M.D., Ph.D.
Pediatrician and Vaccine Scientist

"Immunotherapy saved my life — I was just weeks away from losing my life when a breakthrough treatment gave me a second chance. That’s why I’m proud to support this bond, because no one should be told hope is out of reach when we have the science to save them."

Laurie Adami
Laurie Adami
Cancer Pioneer and Patient Advocate

"This measure is an important part of the equation to help close the gap in health outcomes for black Californians and other vulnerable communities."

Rhonda Smith, Executive Director
California Black Health Network

"The immune system holds one of the most promising pathways to curing diseases that have long evaded treatment. Major initiatives are needed to turn that emerging science into real-world solutions faster — bringing us closer to therapies that save lives."

Elaine Y. Hsiao, Ph.D.
Elaine Y. Hsiao, Ph.D.
Professor & Leading Immunology and Brain Health Researcher

*Partial list

Titles and affiliations are for identification purposes only.